Free Trial

Microsoft (MSFT) Stock Forecast & Price Target

Microsoft logo
$383.52 -5.18 (-1.33%)
Closing price 04:00 PM Eastern
Extended Trading
$383.55 +0.03 (+0.01%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Microsoft - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
27

Based on 29 Wall Street analysts who have issued ratings for Microsoft in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 29 analysts, 2 have given a hold rating, and 27 have given a buy rating for MSFT.

Consensus Price Target

$510.43
33.09% Upside
According to the 29 analysts' twelve-month price targets for Microsoft, the average price target is $510.43. The highest price target for MSFT is $600.00, while the lowest price target for MSFT is $450.00. The average price target represents a forecasted upside of 33.09% from the current price of $383.52.
Get the Latest News and Ratings for MSFT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Microsoft and its competitors.

Sign Up

MSFT Analyst Ratings Over Time

TypeCurrent Forecast
3/18/24 to 3/18/25
1 Month Ago
2/17/24 to 2/16/25
3 Months Ago
12/19/23 to 12/18/24
1 Year Ago
3/19/23 to 3/18/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
27 Buy rating(s)
26 Buy rating(s)
26 Buy rating(s)
36 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$510.43$510.96$508.46$415.00
Forecasted Upside33.09% Upside25.10% Upside16.25% Upside-0.56% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

MSFT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MSFT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Microsoft Stock vs. The Competition

TypeMicrosoftComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.93
2.68
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside31.32% Upside149.92% Upside18.07% Upside
News Sentiment Rating
Positive News

See Recent MSFT News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/13/2025DA Davidson
2 of 5 stars
G. Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$425.00 ➝ $450.00+17.41%
3/7/2025Stifel Nicolaus
4 of 5 stars
Brad Reback
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$515.00 ➝ $475.00+22.67%
1/30/2025UBS Group
4 of 5 stars
Karl Keirstead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$525.00 ➝ $510.00+22.89%
1/30/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rishi Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00 ➝ $500.00+20.41%
1/30/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gregg Moskowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$510.00 ➝ $500.00+13.04%
1/30/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$540.00 ➝ $530.00+19.82%
1/29/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Blakey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$509.00 ➝ $509.00+15.45%
1/27/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$520.00 ➝ $520.00+19.66%
1/24/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
12/23/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$500.00 ➝ $550.00+25.97%
11/19/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Ives
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$550.00+31.65%
10/31/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$470.00 ➝ $465.00+13.84%
10/31/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$495.00 ➝ $475.00+15.76%
10/31/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$500.00 ➝ $495.00+14.44%
10/28/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$600.00 ➝ $600.00+40.27%
10/25/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$501.00 ➝ $500.00+17.72%
10/23/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$500.00 ➝ $497.00+15.50%
10/18/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
10/18/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$490.00 ➝ $505.00+21.18%
10/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$515.00 ➝ $500.00+19.77%
10/8/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
7/17/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$480.00 ➝ $510.00+13.45%
7/9/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$475.00 ➝ $526.00+14.01%
6/13/2024Tigress Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$475.00 ➝ $550.00+24.52%
6/10/2024New Street Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Ferragu
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$570.00+34.48%
5/17/2024Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$460.00 ➝ $475.00+13.24%
4/26/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$450.00 ➝ $480.00+17.41%
4/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$475.00 ➝ $485.00+21.54%
4/1/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$465.00 ➝ $550.00+29.59%
1/31/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$421.00 ➝ $475.00+16.25%
1/18/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$471.00+20.93%
12/5/2023China Renaissance
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$466.00+26.24%
10/26/2023Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$370.00 ➝ $375.00+13.01%
10/26/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$347.00 ➝ $413.00+21.23%
8/11/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$450.00 ➝ $440.00+36.25%
8/9/2023Fundamental Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set TargetHold$298.10-8.06%
5/31/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$350.00 ➝ $420.00+26.81%
5/30/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$340.00 ➝ $380.00+14.15%
4/26/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
4/26/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$290.00 ➝ $330.00+11.98%
Lying in hospital… staring at the light (Ad)

"Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune. After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him.

[Click here] to learn more about this powerful strategy and discover your own financial "Second Life
4/26/2023Moffett Nathanson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$263.00 ➝ $306.00+3.83%
4/26/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$330.00 ➝ $350.00+27.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:41 PM ET.


Should I Buy Microsoft Stock? MSFT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, March 12, 2025. Please send any questions or comments about these Microsoft pros and cons to contact@marketbeat.com.

Microsoft
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Microsoft:

  • Microsoft has a strong market capitalization of $2.85 trillion, indicating its significant presence and stability in the tech industry, which can provide a sense of security for investors.
  • The company reported a robust earnings per share (EPS) of $3.23, exceeding analysts' expectations, showcasing its strong profitability and operational efficiency.
  • With a current stock price around $414.68, which is near its fifty-day moving average, it may present a favorable entry point for investors looking to capitalize on potential growth.
  • Microsoft's diverse product offerings, including the latest versions of Microsoft 365 and Azure cloud services, position it well for continued revenue growth in the expanding cloud computing market.
  • The company has a solid dividend yield of 0.87% with a payout ratio of 26.73%, indicating a commitment to returning value to shareholders while maintaining sufficient reinvestment in the business.

Microsoft
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Microsoft for these reasons:

  • Despite its strong performance, Microsoft has a relatively high P/E ratio of 30.89, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
  • The company has faced recent downgrades from analysts, with some lowering their target prices, indicating a lack of confidence in short-term growth prospects.
  • Microsoft's beta of 0.92 suggests that its stock is less volatile than the market, which may limit potential gains during bullish market conditions.
  • With a debt-to-equity ratio of 0.13, while low, it indicates that the company is not leveraging debt for growth, which could be a disadvantage in a competitive market where aggressive investment is necessary.
  • Recent market trends show increasing competition in cloud services, which could impact Microsoft's market share and profitability in the long run.

MSFT Forecast - Frequently Asked Questions

According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for Microsoft is $510.43, with a high forecast of $600.00 and a low forecast of $450.00.

29 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Microsoft in the last twelve months. There are currently 2 hold ratings and 27 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MSFT shares.

According to analysts, Microsoft's stock has a predicted upside of 33.09% based on their 12-month stock forecasts.

Over the previous 90 days, Microsoft's stock had 2 upgrades by analysts.

Microsoft has been rated by research analysts at Cantor Fitzgerald, DA Davidson, Guggenheim, Loop Capital, Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Stifel Nicolaus, and UBS Group in the past 90 days.

Analysts like Microsoft more than other "computer and technology" companies. The consensus rating score for Microsoft is 2.93 while the average consensus rating score for "computer and technology" companies is 2.69. Learn more on how MSFT compares to other companies.


This page (NASDAQ:MSFT) was last updated on 3/18/2025 by MarketBeat.com Staff
From Our Partners